Related Experiment Video
Updated: May 21, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac power index: staging heart failure for mechanical circulatory support
S G Hall1, J Garcia, D F Larson
1Circulatory Sciences Graduate Perfusion Program, The University of Arizona, Tucson, Arizona, USA.
Perfusion
|June 15, 2012
Summary
Cardiac power index effectively quantifies cardiac reserve in heart failure patients. A cardiac power index below 0.34 Watts/m² indicates higher mortality risk post-mechanical circulatory support implantation.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Background:
- Cardiac reserve is crucial for assessing heart failure severity.
- Quantifying cardiac reserve aids in determining optimal treatment timing for advanced heart failure.
Purpose of the Study:
- To evaluate the utility of cardiac power index (CPI) in staging heart failure.
- To determine the optimal timing for mechanical circulatory support (MCS) implantation using CPI.
Main Methods:
- Retrospective analysis of 28 heart failure patients undergoing MCS implantation.
- Comparison of CPI with other hemodynamic parameters.
- Analysis of patient survival based on pre-implantation CPI and drug therapy levels.
Main Results:
- Cardiac power index was the sole significant hemodynamic parameter identifying cardiac reserve (p<0.05).
- A CPI threshold of 0.34 Watts/m² was associated with increased 90-day mortality post-MCS implantation.
Conclusions:
- Cardiac reserve, as measured by CPI, is a key determinant of survival after MCS implantation.
- MCS implantation is recommended before CPI drops below the 0.34 Watts/m² threshold to improve patient outcomes.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...